1-8 of 8
Nils B. Jørgensen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

1613-P: Feasibility of Time-Restricted Eating in the Treatment of Type 2 Diabetes—The RESET2 Pilot Study

ANNE-DITTE TERMANNSEN, ANNEMARIE R. VARMING, GITTE S.H. STAGE HANSEN, NATASJA BJERRE, FREDERIK PERSSON, JONATAN I. BAGGER, SR., NILS B. JØRGENSEN, NANA F. HEMPLER, KRISTINE FAERCH, JONAS S. QUIST
Journal: Diabetes
Diabetes 2023;72(Supplement_1):1613-P
https://doi.org/10.2337/db23-1613-P
Published: 20 June 2023
View article titled, 1613-P: Feasibility of Time-Restricted Eating in the Treatment of Type 2 Diabetes—The RESET2 Pilot Study
Journal Articles

The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery

Morten Hindsø, Nora Hedbäck, Maria S. Svane, Andreas Møller, Christoffer Martinussen, Nils B. Jørgensen, Carsten Dirksen, Lærke S. Gasbjerg, Viggo B. Kristiansen, Bolette Hartmann, Mette M. Rosenkilde, Jens J. Holst, Sten Madsbad, Kirstine N. Bojsen-Møller
Journal: Diabetes
Diabetes 2023;72(3):336–347
https://doi.org/10.2337/db22-0568
Published: 07 December 2022
View article titled, The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery
Open the PDF for The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery in another window
Meeting Abstracts

321-OR: Empagliflozin Improves Beta-Cell Function Independently of Glucose Toxicity in Patients with Type 2 Diabetes

ROOPAMEERA THIRUMATHYAM, ERIK A. RICHTER, JENS PETER GOETZE, PER L. MADSEN, JENS J. HOLST, STEN MADSBAD, SR., NILS B. JØRGENSEN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):321-OR
https://doi.org/10.2337/db22-321-OR
Published: 01 June 2022
View article titled, 321-OR: Empagliflozin Improves Beta-Cell Function Independently of Glucose Toxicity in Patients with Type 2 Diabetes
Meeting Abstracts

1425-P: Effect of Ghrelin on Glucose Tolerance after Sleeve Gastrectomy

NORA HEDBÄCK, MARIE-LOUISE DICHMAN, CARSTEN DIRKSEN, KIRSTINE N. BOJSEN-MOLLER, NILS B. JØRGENSEN, MORTEN G. HINDSØ, VIGGO B. KRISTIANSEN, JENS J. HOLST, MARIA S. SVANE, STEN MADSBAD, SR.
Journal: Diabetes
Diabetes 2022;71(Supplement_1):1425-P
https://doi.org/10.2337/db22-1425-P
Published: 01 June 2022
View article titled, 1425-P: Effect of Ghrelin on Glucose Tolerance after Sleeve Gastrectomy
Meeting Abstracts

876-P: Empagliflozin-Induced Metabolic Changes and Cardiac Function in Patients with Type 2 Diabetes: A Randomized Crossover MRI Study with Insulin as Comparator

ROOPAMEERA THIRUMATHYAM, JENS PETER GOETZE, JENS J. HOLST, NIELS VEJLSTRUP, STEN MADSBAD, SR., PER L. MADSEN, NILS B. JØRGENSEN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):876-P
https://doi.org/10.2337/db22-876-P
Published: 01 June 2022
View article titled, 876-P: Empagliflozin-Induced Metabolic Changes and Cardiac Function in Patients with Type 2 Diabetes: A Randomized Crossover MRI Study with Insulin as Comparator
Meeting Abstracts

1917-P: Primary Weight Loss Failure after Gastric Bypass Is Characterized by Impaired Gut-Hormone-Mediated Suppression of Food Intake

KIRSTINE N. BOJSEN-MOLLER, MARIA S. SVANE, CHRISTOFFER MARTINUSSEN, CARSTEN DIRKSEN, NILS B. JØRGENSEN, VIGGO BJERREGAARD KRISTIANSEN, BOLETTE HARTMANN, JENS J. HOLST, STEN MADSBAD
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1917-P
https://doi.org/10.2337/db19-1917-P
Published: 01 June 2019
View article titled, 1917-P: Primary Weight Loss Failure after Gastric Bypass Is Characterized by Impaired Gut-Hormone-Mediated Suppression of Food Intake
Journal Articles

Early Enhancements of Hepatic and Later of Peripheral Insulin Sensitivity Combined With Increased Postprandial Insulin Secretion Contribute to Improved Glycemic Control After Roux-en-Y Gastric Bypass

Kirstine N. Bojsen-Møller, Carsten Dirksen, Nils B. Jørgensen, Siv H. Jacobsen, Annette K. Serup, Peter H. Albers, Dorte L. Hansen, Dorte Worm, Lars Naver, Viggo B. Kristiansen, Jørgen F.P. Wojtaszewski, Bente Kiens, Jens J. Holst, Erik A. Richter, Sten Madsbad
Journal: Diabetes
Diabetes 2014;63(5):1725–1737
https://doi.org/10.2337/db13-1307
Published: 12 April 2014
View article titled, Early Enhancements of Hepatic and Later of Peripheral Insulin Sensitivity Combined With Increased Postprandial Insulin Secretion Contribute to Improved Glycemic Control After Roux-en-Y Gastric Bypass
Open the PDF for Early Enhancements of Hepatic and Later of Peripheral Insulin Sensitivity Combined With Increased Postprandial Insulin Secretion Contribute to Improved Glycemic Control After Roux-en-Y Gastric Bypass in another window
Journal Articles

Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes

Nils B. Jørgensen, Carsten Dirksen, Kirstine N. Bojsen-Møller, Siv H. Jacobsen, Dorte Worm, Dorte L. Hansen, Viggo B. Kristiansen, Lars Naver, Sten Madsbad, Jens J. Holst
Journal: Diabetes
Diabetes 2013;62(9):3044–3052
https://doi.org/10.2337/db13-0022
Published: 15 August 2013
View article titled, Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes
Open the PDF for Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes in another window